A Study to Evaluate LB1148 for Return of Gastrointestinal Function and Adhesions in Subjects Undergoing Bowel Resection
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish preliminary evidence of the efficacy, safety, and
tolerability of LB1148 for the treatment of post-operative ileus and intra-abdominal
adhesions in subjects undergoing elective bowel resection.